Newlin Investment Company 1, LLC 13D and 13G filings for Carmell Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 09:12 am Unchanged | 2025-02-07 | 13G | Carmell Therapeutics Corporation CTCX | Newlin Investment Company 1, LLC | 1,279,941 4.200% | 0 (Unchanged) | Filing |
| 2025-01-08 09:05 am Purchase | 2024-12-31 | 13G | Carmell Therapeutics Corporation CTCX | Newlin Investment Company 1, LLC | 1,279,941 6.100% | 30,879 (+2.47%) | Filing |
| 2024-02-06 7:59 pm Purchase | 2023-12-31 | 13G | Carmell Therapeutics Corporation CTCX | Newlin Investment Company 1, LLC | 1,249,062 5.400% | 1,249,062 (New Position) | Filing |